MicroStrategy $750 million at-the-market offering
The stock is listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Atara Biotherapeutics $100 million at-the-market offering
The stock is listed on Nasdaq
OPAL Fuels $75 million at-the-market offering
The stock is listed on Nasdaq
Spirit AeroSystems $460 million stock and exchangeable notes offering
The stock is listed on the New York Stock Exchange
TKO Group Holdings $666 million secondary offering
The stock is listed on the New York Stock Exchange
CCC Intelligent Solutions Holdings $683 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Alector $125 million at-the-market offering
The common stock is listed on the Nasdaq Global Select Market
NeuroPace $50 million at-the-market offering
The stock is listed on the Nasdaq Global Market
TD SYNNEX $648 million secondary offering
The shares are listed on the NYSE
Roivant Sciences registered direct offering and investment in Immunovant
We advised Roivant on the transactions